Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

• Главные авторы: Robert A Harrison (Автор), George O Oluoch (Автор), Stuart Ainsworth (Автор), Jaffer Alsolaiss (Автор), Fiona Bolton (Автор), Ana-Silvia Arias (Автор), José-María Gutiérrez (Автор), Paul Rowley (Автор), Stephen Kalya (Автор), Hastings Ozwara (Автор), Nicholas R Casewell (Автор)
• Формат: ‌
• Опубликовано: Public Library of Science (PLoS), 2017-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

<h4>Background</h4>Antivenom is the treatment of choice for snakebite, which annually kills an estimated 32,000 people in sub-Saharan Africa and leaves approximately 100,000 survivors with permanent physical disabilities that exert a considerable socioeconomic burden. Over the past two d...